EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,437,442 | +24.7% | 157,320 | +9.1% | 0.01% | +25.0% |
| Q2 2023 | $2,755,509 | -17.3% | 144,192 | -16.0% | 0.00% | -20.0% |
| Q1 2023 | $3,332,173 | +7.2% | 171,673 | -11.4% | 0.01% | 0.0% |
| Q4 2022 | $3,106,980 | +1.1% | 193,702 | -1.2% | 0.01% | -16.7% |
| Q3 2022 | $3,074,000 | -21.5% | 196,016 | +4.2% | 0.01% | -14.3% |
| Q2 2022 | $3,916,000 | -5.6% | 188,060 | +2.8% | 0.01% | +16.7% |
| Q1 2022 | $4,148,000 | +180.3% | 182,974 | +168.0% | 0.01% | +100.0% |
| Q1 2017 | $1,480,000 | +29.0% | 68,273 | -11.3% | 0.00% | 0.0% |
| Q4 2016 | $1,147,000 | +15.9% | 76,982 | -0.6% | 0.00% | +50.0% |
| Q3 2016 | $990,000 | – | 77,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |